AXS Investments’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,208
Closed -$1.38M 160
2025
Q1
$1.38M Sell
5,208
-583
-10% -$144K 0.38% 102
2024
Q4
$1.34M Sell
5,791
-262
-4% -$60.2K 0.37% 112
2024
Q3
$1.34M Buy
6,053
+101
+2% +$20.9K 0.35% 134
2024
Q2
$1.17M Buy
5,952
+350
+6% +$72.3K 0.33% 138
2024
Q1
$1.21M Sell
5,602
-119
-2% -$25K 0.29% 149
2023
Q4
$1.2M Sell
5,721
-425
-7% -$90.7K 0.29% 143
2023
Q3
$1.23M Sell
6,146
-481
-7% -$95.6K 0.32% 98
2023
Q2
$1.23M Buy
6,627
+519
+8% +$95.9K 0.33% 117
2023
Q1
$1.17M Sell
6,108
-502
-8% -$90.8K 0.39% 96
2022
Q4
$1.11M Buy
6,610
+1,214
+22% +$211K 0.4% 91
2022
Q3
$956K Buy
5,396
+411
+8% +$81.2K 0.37% 85
2022
Q2
$1.02M Buy
+4,985
New +$1.06M 0.36% 86

Other funds holding CME

AXS Investments's CME Position: Q2 2025 in Review

AXS Investments sold out of CME Group (CME) in Q2 2025, closing a stake of 5,208 shares — an estimated $1.38M sold.

AXS Investments first reported a position in CME in Q2 2022 and held it in 12 quarters. The position peaked at $1.38M in Q1 2025. 1,660 funds tracked by Wall St. Rank hold CME as of Q2 2025.

  • AXS Investments reported no remaining CME Group position as of Q2 2025 after selling out during the quarter.
  • AXS Investments sold 5,208 CME Group shares in Q2 2025, an estimated $1.38M.
  • AXS Investments first reported a position in CME Group in Q2 2022 and held it in 12 quarters.
  • AXS Investments's CME Group position peaked at $1.38M in Q1 2025.
  • 1,660 funds tracked by Wall St. Rank held CME Group as of Q2 2025.

Based on AXS Investments's 13F filing for Q2 2025, filed 11 Aug 2025.